Alterity Therapeutics to Present at the MST Access Australian Micro & Small Caps Conference
Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases, today announced that Dr David Stamler, Chief Executive Officer will present a company overview at the MST Access Australian Micro & Small Caps Conference on Thursday 17 June 2021 at 9:15 a.m. AEST / Wednesday 16th June at 4.15pm PDT.
To join the presentation, please click the webinar link below:
Authorisation & Additional information
This announcement was authorized by David Stamler, CEO of Alterity Therapeutics Limited.